Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459) |
---|
09/03/2009 | US20090220662 Isosorbide derivatives and their use as flavor modifiers, tastants, and taste enhancers |
09/03/2009 | US20090220454 Use of the histone deacetylase inhibitor N-hydroxy-4-[2-(3-dimethylaminobenzofuran-2-ylcarbonylamino)ethoxy]benzamide (aka CRA-24781, PCI-24781) for treating myelogenous leukemia (MML) or acute myelogenous leukemia (AML), optionally in combination therapy |
09/02/2009 | EP2094675A1 A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one |
09/02/2009 | EP2094674A1 A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one |
09/02/2009 | EP2094673A1 Compounds and methods for inhibiting the interaction of bcl proteins with binding partners |
09/02/2009 | EP2094645A1 2-hydroxy-1,3-diaminopropane derivatives |
09/01/2009 | US7582668 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
08/27/2009 | WO2009105509A1 Amine and ether compounds which modulate the cb2 receptor |
08/27/2009 | US20090216013 e.g.1,1-Dicyclohexyl-3-[5-(pyridin-2-ylsulfanyl)-thiazol-2-yl]-urea; useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial, in particular, type 2 diabetes |
08/27/2009 | US20090215795 Cyclic amidine derivatives |
08/27/2009 | US20090215768 Isoxazole derivatives and pharmaceutical compositions comprising the same |
08/27/2009 | US20090215624 Alkoxyalkyl Spirocyclic Tetramic Acids and Tetronic Acids |
08/27/2009 | CA2716515A1 Amine and ether compounds which modulate the cb2 receptor |
08/26/2009 | CN101516839A Compounds which modulate the cb2 receptor |
08/25/2009 | US7579465 For treatment of picornavirus infections in mammals |
08/25/2009 | US7579313 Transglutaminase inhibitors and methods of use thereof |
08/20/2009 | WO2009101082A1 Substituted sulfonic acid amide compounds |
08/19/2009 | CN100528849C Process for the preparation of 1,2-dichloroethane free crystals of zonisamide and high pure crystals of zonisamide |
08/19/2009 | CN100528154C Malonyl-COA decarboxylase inhibitors useful as metabolic modulators |
08/18/2009 | US7576108 Substituted arylcyclopropylacetamides as glucokinase activators |
08/13/2009 | WO2009003719A3 Indane-amine derivatives, their preparation and use as medicaments |
08/12/2009 | EP2086948A2 Inhibitors of phosphodiesterase type-iv |
08/12/2009 | CN101506148A Inhibitors for GLYT-1 |
08/06/2009 | US20090197928 Novel Receptor Antagonists and Their Methods of Use |
08/05/2009 | EP2083816A2 Heterocyclic amide compounds useful as kinase inhibitors |
08/05/2009 | EP2029559B1 Aryl-4-ethynyl-isoxazole derivatives |
08/05/2009 | EP1888541B1 Benzo(d)isoxazol-3-yl-amine compounds and their use as vanilloid receptor ligands |
08/05/2009 | EP1249233B9 Npyy5 antagonists |
08/05/2009 | CN101500986A Di-aromatic substituted amides as inhibitors for GLYT1 |
08/05/2009 | CN100522952C Insecticidal phthalamide derivatives |
08/05/2009 | CN100522174C Crystalline isoxazole derivative and medical preparation thereof |
08/04/2009 | US7569727 Pesticidally active ketone and oxime derivatives |
08/04/2009 | US7569601 Such as (2E)-3-{4-[1-ethyl-2,2-bis(4-hydroxyphenyl)ethenyl]phenyl}-2-propenoic acid; for selective estrogen receptor modulation; menopausal or postmenopausal disorders, vasomotor symptoms, urogenital or vulvar vaginal atrophy, atrophic vaginitis, female sexual dysfunction, breast cancer, osteoporosis |
07/29/2009 | EP2081905A2 Sulfonyl compounds which modulate the cb2 receptor |
07/29/2009 | CN101492416A Compounds effecting glucokinase |
07/28/2009 | US7566803 Vitamin D receptor modulators |
07/28/2009 | US7566715 Substituted sulfonamide compounds useful for the prophylaxis and treatment of conditions relating to obesity, type II diabetes and/or disorders of the central nervous system |
07/23/2009 | US20090186905 Anaplastic lymphoma kinase modulators and methods of use |
07/22/2009 | EP2080752A1 Pesticidally active ketone and oxime derivatives |
07/22/2009 | EP2006286A9 Isoxazole derivative and isothiazole derivative having inhibitory activity on 11 beta -hydroxysteroid dehydrogenase type i |
07/22/2009 | EP1391456B1 2-iminoimidazole derivatives |
07/22/2009 | CN101490021A Insecticidal compounds |
07/16/2009 | US20090181970 Functionalized diarylisoxazoles inhibitors of ciclooxygenase |
07/14/2009 | US7560589 Cycloalkylidene compounds as modulators of estrogen receptor |
07/14/2009 | US7560561 Such as terfenadine carboxylic acid metabolite and carebastine using a 4-(4-halo-1-oxobutyl)-alpha,alpha-dimethyl-alpha-substituted toluene intermediate |
07/09/2009 | WO2008154642A3 Antibacterial agents |
07/09/2009 | US20090176782 Inhibitors of tace |
07/08/2009 | EP2076133A2 Synthesis of enone intermediate |
07/08/2009 | CN101479238A Amine derivative having npyy5 receptor antagonist activity |
07/08/2009 | CN100509790C Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses |
07/08/2009 | CN100509759C Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives |
07/07/2009 | US7557133 Such as (3S)-5-[(2,6-dichlorobenzoyl)oxy]-3-({[5-methyl-3-phenyl-4,5-dihydro-5-isoxazolyl]carbonyl}amino)-4-oxopentanoic acid for preventing inflammation and apoptosis; crystallization |
07/07/2009 | CA2438324C Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
07/02/2009 | WO2009081892A1 Novel catechol derivative, pharmaceutical composition containing the same, and use of those |
07/02/2009 | US20090170911 Novel azole compound |
07/02/2009 | US20090170824 Diarylsulfones as 5-HT2A Antagonists |
07/01/2009 | EP2074084A1 Compounds which modulate the cb2 receptor |
07/01/2009 | EP1756043B1 Ortho substituted aryl or heteroaryl amide compounds |
07/01/2009 | EP1423362B1 New mandelic acid derivative and its use as thrombin inhibitor |
07/01/2009 | CN100506788C Arylalkylcarbamate derivatives production and use thereof in therapy |
06/30/2009 | US7553972 Benzamide inhibitors of the P2X7 receptor |
06/30/2009 | US7553966 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
06/30/2009 | CA2406088C Novel phenyl-propargylether derivatives |
06/25/2009 | WO2009077197A1 Insecticidal compounds |
06/25/2009 | WO2009025983A4 Method for preparing 5-haloalkyl-4,5-dihydroisoxazole derivatives |
06/25/2009 | US20090163549 Pharmaceutical Composition Comprising an Amide Derivative |
06/25/2009 | CA2707612A1 Insecticidal compounds |
06/24/2009 | CN100503576C Substituted azole compounds, preparation and application thereof |
06/23/2009 | US7550489 N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide and phentermine, metformin, or bupropion; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists |
06/18/2009 | WO2009075080A1 Fluoroalkylsulfide derivative and pest control agent |
06/18/2009 | US20090156643 Substituted isoxazoline compound and pesticide |
06/17/2009 | EP2069020A2 Benzo[d]isoxazole derivatives as c-kit tyrosine kinase inhibitors for the treatment of disorders associated with the over production of histamine |
06/17/2009 | EP1611088B1 Hydroxamates as therapeutic agents |
06/17/2009 | CN101456846A Novel method for synthesizing acetyl-sulfisoxazole |
06/16/2009 | CA2447640C Substituted anilide derivative, intermediate thereof, agricultural and horticultural chemical and its usage |
06/11/2009 | WO2009051718A3 Calcium receptor modulating agents |
06/11/2009 | US20090149459 P38 inhibitors and methods of use thereof |
06/11/2009 | US20090149445 Tricyclic steroid hormone nuclear receptor modulators |
06/11/2009 | US20090149425 Malononitrile compound as pesticides |
06/11/2009 | US20090149415 Compounds for modulating the glycolysis enzyme complex and/or the transaminase complex |
06/10/2009 | EP2066620A1 Di-aromatic substituted amides as inhibitors for glyt1 |
06/10/2009 | CN101454298A Novel crystal of 3-[5-[4-(cyclopentyloxy)-2- hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6- yl)methoxy]phenyl]propionic acid |
06/10/2009 | CN101454297A Aryl-4-ethynyl-isoxazole derivatives |
06/09/2009 | US7544704 Aryl-4-ethynyl-isoxazole derivatives |
06/09/2009 | US7544701 Central nervous system disorders; psychological disorders |
06/04/2009 | WO2009069643A1 Solid dispersion comprising 3-[5-[4-(cyclopentyloxy)- 2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6- yl)methoxy]phenyl]propionic acid or salt thereof, or composition comprising the solid dispersion |
06/04/2009 | WO2009068557A1 Novel phenyl-acetamide and phenyl-propionamide derivatives useful as potassium channel modulators |
06/04/2009 | WO2009068509A1 Novel benzamide derivatives useful as potassium channel modulators |
06/04/2009 | US20090143435 GABA enhancers in the treatment of diseases relating to reduced neurosteroid activity |
06/04/2009 | US20090143422 P38 inhibitors and methods of use thereof |
06/04/2009 | US20090143365 Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors |
06/04/2009 | US20090143358 Inhibitors of ion channels |
06/04/2009 | CA2707133A1 Chiral 3-(benzylsulfinyl)-5,5-dimethyl-4,5-dihydroisoxazole derivatives and 5,5-dimethyl-3-[(1h-pyrazol-4-ylmethyl)sulfinyl]-4,5-dihydroisoxazole derivatives, method for the production thereof, and use of same as herbicides and plant growth regulators |
06/03/2009 | EP2065373A1 Chiral 3-(benzylsulfinyl)-5,5-dimethyl-4,5-dihydroisoxazole and 5,5-dimethyl-3-[(1H-pyrazol-4-ylmethyl) sulfinyl]-4,5-dihydroisoxazole derivatives, methods for their preparation and their use as herbicides and plant growth regulators |
06/03/2009 | EP2064207A2 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
06/03/2009 | EP2064194A2 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
06/03/2009 | EP2064193A1 Heterocyclic gpr40 modulators |
06/03/2009 | EP2064192A2 Compounds and methods for inhibiting the interaction of bcl proteins with binding partners |
06/03/2009 | EP1140079B1 Assays for ligands for nuclear receptors |
06/03/2009 | CN100494177C Bi-amido heterocyclic derivative with antitumour activity and its preparation method and use |